# EDGAR Filing Document

**Accession Number:** 0001691249
**File Stem:** 0001903596-23-000118
**Filing Date:** 2023-2
**Character Count:** 3430
**Document Hash:** 994a92e94a9d752ca9f1d2c1196d2e1c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001903596-23-000118.hdr.sgml**: 20230314

**ACCESSION NUMBER**: 0001903596-23-000118

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230209

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Iremedy Healthcare Companies, Inc.
- **CENTRAL INDEX KEY:** 0001691249
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES [5047]
- **IRS NUMBER:** 260255855
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 2862 SE MONROE ST.
- **CITY:** STUART
- **STATE:** FL
- **ZIP:** 34997
- **BUSINESS PHONE:** 321-250-1434

**MAIL ADDRESS:**
- **STREET 1:** 2862 SE MONROE ST.
- **CITY:** STUART
- **STATE:** FL
- **ZIP:** 34997

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Iremedy Healthcare, Inc.
- **DATE OF NAME CHANGE:** 20161130

**The iRemedy Healthcare Companies, Inc.**

7118 South Kanner Highway

Stuart, Florida 34997

(407) 395-4283

February 9, 2023

Office of Trade & Services

Division of Corporation Finance

Securities and Exchange Commission

100 F. Street, N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| Re: | The iRemedy Healthcare Companies, Inc. |
|  | Offering Statement on Form 1-A |
|  | Filed on September 29, 2022 |
|  | File No. 024-12009 |

---

**<u>Acceleration Request</u>**

Requested Date: February 13, 2023

Requested Time: 4:00 pm Eastern Time

Dear Sir or Madam:

The iRemedy Healthcare Companies, Inc. (the "Company") hereby requests that the Securities and Exchange Commission (the "Commission") take appropriate action to declare the above-captioned Offering Statement on Form 1-A qualified at the "Requested Date" and "Requested Time" set forth above or as soon thereafter as practicable.

The Company hereby authorizes Craig D. Linder, who is an attorney with the Company's outside legal counsel, Anthony L.G., PLLC, to orally modify or withdraw this request for acceleration.

The Company hereby acknowledges that:

● should the Commission or the staff of the Commission, acting pursuant to delegated authority, declare the filing qualified, it does not foreclose the Commission from taking any action with respect to the filing;

● the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing qualified, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

● the Company may not assert the staff comments and the declaration of qualification as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

The Company also agrees that it will only sell shares of its common stock pursuant to the subject Offering Statement in states where the offering is registered or where there is an applicable exemption from the applicable state's securities law available.

The Company requests that it be notified of such qualification by a telephone call to Craig D. Linder, Esq. at (561) 514-0936 or email to him at: clinder@anthonypllc.com.

<br> Very truly yours, <br>

---

| | |
|:---|:---|
| <br> **The iRemedy Healthcare Companies, Inc.** | <br> **The iRemedy Healthcare Companies, Inc.** |
| By: | */s/ Anthony Paquin* |
|  | Anthony Paquin |
|  | Chief Executive Officer |

---